| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | FBLN1 RELN FBLN2 FBN1 FBN2 LAMA1 LAMA5 LTBP2 LTBP4 SSPOP FBN3 NPNT | 2.13e-11 | 188 | 84 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 DSC1 CELSR3 DSC2 DSG1 LRP2 UMOD EGFLAM LTBP2 LTBP4 LRP1B FBN3 NPNT STAB1 | 2.65e-11 | 749 | 84 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.10e-07 | 16 | 84 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.65e-06 | 21 | 84 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.54e-05 | 12 | 84 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.71e-05 | 268 | 84 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.53e-05 | 14 | 84 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | structural molecule activity | FBLN1 RELN FBLN2 FBN1 FBN2 LAMA1 LAMA5 LTBP2 LTBP4 SSPOP FBN3 CLDN9 NPNT | 8.45e-05 | 891 | 84 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | integrin binding | 9.60e-05 | 175 | 84 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.55e-04 | 85 | 84 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 4.82e-04 | 8 | 84 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | heparin binding | 1.30e-03 | 192 | 84 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.65e-03 | 120 | 84 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | cholesterol binding | 1.88e-03 | 58 | 84 | 3 | GO:0015485 | |
| GeneOntologyBiologicalProcess | kidney development | 3.04e-06 | 372 | 85 | 10 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 4.21e-06 | 386 | 85 | 10 | GO:0072001 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.31e-05 | 285 | 85 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.37e-05 | 286 | 85 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | nephron development | 8.33e-05 | 174 | 85 | 6 | GO:0072006 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 9.20e-05 | 110 | 85 | 5 | GO:0072080 | |
| GeneOntologyBiologicalProcess | positive regulation of alkaline phosphatase activity | 1.00e-04 | 4 | 85 | 2 | GO:0010694 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.00e-04 | 4 | 85 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | renal tubule development | 1.18e-04 | 116 | 85 | 5 | GO:0061326 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.62e-04 | 124 | 85 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 1.88e-04 | 128 | 85 | 5 | GO:0072009 | |
| GeneOntologyBiologicalProcess | ureteric bud morphogenesis | 2.48e-04 | 74 | 85 | 4 | GO:0060675 | |
| GeneOntologyBiologicalProcess | regulation of alkaline phosphatase activity | 2.49e-04 | 6 | 85 | 2 | GO:0010692 | |
| GeneOntologyBiologicalProcess | mesonephric tubule morphogenesis | 3.04e-04 | 78 | 85 | 4 | GO:0072171 | |
| GeneOntologyBiologicalProcess | axon development | 3.05e-04 | 642 | 85 | 10 | GO:0061564 | |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 3.07e-04 | 32 | 85 | 3 | GO:0021952 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 3.79e-04 | 149 | 85 | 5 | GO:0010811 | |
| GeneOntologyBiologicalProcess | nephron tubule morphogenesis | 4.61e-04 | 87 | 85 | 4 | GO:0072078 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 4.62e-04 | 8 | 85 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | reelin-mediated signaling pathway | 4.62e-04 | 8 | 85 | 2 | GO:0038026 | |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 5.02e-04 | 89 | 85 | 4 | GO:0072088 | |
| GeneOntologyBiologicalProcess | axonogenesis | 5.35e-04 | 566 | 85 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 5.46e-04 | 91 | 85 | 4 | GO:0072028 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 5.56e-04 | 162 | 85 | 5 | GO:0072073 | |
| GeneOntologyBiologicalProcess | tube development | CFH FLNA PDE3B FBN1 MYLK BRCA1 HS2ST1 LAMA1 ADAMTS16 LRP2 LAMA5 UMOD JMJD1C NPNT STAB1 | 5.59e-04 | 1402 | 85 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | renal tubule morphogenesis | 5.93e-04 | 93 | 85 | 4 | GO:0061333 | |
| GeneOntologyCellularComponent | extracellular matrix | FBLN1 RELN FBLN2 FBN1 FBN2 ADAMTS3 LAMA1 ADAMTS16 LAMA5 EGFLAM MUC5B LTBP2 ADAM11 LTBP4 SSPOP FBN3 NPNT | 9.90e-10 | 656 | 85 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FBLN1 RELN FBLN2 FBN1 FBN2 ADAMTS3 LAMA1 ADAMTS16 LAMA5 EGFLAM MUC5B LTBP2 ADAM11 LTBP4 SSPOP FBN3 NPNT | 1.04e-09 | 658 | 85 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FBLN1 RELN FBLN2 FBN1 FBN2 ADAMTS3 LAMA1 LAMA5 EGFLAM LTBP2 ADAM11 LTBP4 SSPOP NPNT | 2.79e-08 | 530 | 85 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 1.77e-07 | 13 | 85 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 1.05e-05 | 122 | 85 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | perikaryon | 3.49e-05 | 223 | 85 | 7 | GO:0043204 | |
| GeneOntologyCellularComponent | desmosome | 1.97e-04 | 28 | 85 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | laminin complex | 7.20e-04 | 10 | 85 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | gamma-tubulin ring complex | 8.78e-04 | 11 | 85 | 2 | GO:0000931 | |
| HumanPheno | Abnormal heart valve morphology | FLNA FLNC NEK1 FBN1 FBN2 BRF1 MYLK BRCA1 DSG1 SZT2 SCN1B MUC5B LTBP2 NEK9 JMJD1C | 1.27e-05 | 588 | 39 | 15 | HP:0001654 |
| HumanPheno | Choroidal neovascularization | 2.34e-05 | 23 | 39 | 4 | HP:0011506 | |
| HumanPheno | Abnormal heart valve physiology | FLNA FLNC NEK1 FBN1 FBN2 MYLK DSG1 SZT2 SCN1B MUC5B LTBP2 NEK9 | 2.79e-05 | 403 | 39 | 12 | HP:0031653 |
| HumanPheno | Limited knee extension | 4.54e-05 | 27 | 39 | 4 | HP:0003066 | |
| HumanPheno | Abnormal morphology of the choroidal vasculature | 5.27e-05 | 28 | 39 | 4 | HP:0025568 | |
| HumanPheno | Middle age onset | 8.55e-05 | 251 | 39 | 9 | HP:0003596 | |
| HumanPheno | Abnormality of the calf | 9.41e-05 | 384 | 39 | 11 | HP:0002981 | |
| HumanPheno | Abnormal cardiac septum morphology | FLNA NEK1 RELN FBN1 FBN2 BRF1 BRCA1 DSG1 SZT2 SCN1B LRP2 LAMA5 LTBP2 LTBP4 NEK9 JMJD1C | 1.03e-04 | 787 | 39 | 16 | HP:0001671 |
| HumanPheno | Limitation of knee mobility | 1.30e-04 | 35 | 39 | 4 | HP:0010501 | |
| HumanPheno | Abnormal upper to lower segment ratio | 1.71e-04 | 3 | 39 | 2 | HP:0012772 | |
| HumanPheno | Inferior cerebellar vermis hypoplasia | 1.77e-04 | 15 | 39 | 3 | HP:0007068 | |
| MousePheno | abnormal uvea morphology | CFH VLDLR FLNA AGAP5 DSG1 HS2ST1 LTBP2 AGAP11 AGAP9 AGAP6 JMJD1C | 7.81e-08 | 241 | 77 | 11 | MP:0005197 |
| MousePheno | abnormal iris morphology | 9.33e-08 | 192 | 77 | 10 | MP:0001322 | |
| MousePheno | abnormal anterior uvea morphology | 1.31e-07 | 199 | 77 | 10 | MP:0005194 | |
| MousePheno | cornea opacity | 2.54e-06 | 159 | 77 | 8 | MP:0001314 | |
| MousePheno | abnormal anterior eye segment morphology | NPC1 CFH TRIM33 FLNA AGAP5 FBN2 DSC1 DSC2 DSG1 HS2ST1 LAMA1 TMEM104 LTBP2 AGAP11 C7 SPIDR AGAP9 AGAP6 JMJD1C | 7.02e-06 | 1117 | 77 | 19 | MP:0005193 |
| MousePheno | fused cornea and lens | 8.32e-06 | 24 | 77 | 4 | MP:0001307 | |
| MousePheno | abnormal cornea morphology | 3.08e-05 | 366 | 77 | 10 | MP:0001312 | |
| MousePheno | overexpanded pulmonary alveolus | 4.90e-05 | 37 | 77 | 4 | MP:0001183 | |
| MousePheno | emphysema | 4.90e-05 | 37 | 77 | 4 | MP:0001958 | |
| MousePheno | abnormal skin coloration | 6.30e-05 | 182 | 77 | 7 | MP:0011239 | |
| MousePheno | abnormal skin morphology | AGAP5 FBLN1 NIBAN1 RELN GGNBP2 FBN1 OVOL1 FBN2 LDLRAD1 DSC1 BRCA1 ADAMTS3 LAMA5 MUC5B AGAP11 AGAP9 LTBP4 AGAP6 NEK9 TARBP1 | 8.54e-05 | 1455 | 77 | 20 | MP:0002060 |
| MousePheno | abnormal pulmonary acinus morphology | 1.64e-04 | 284 | 77 | 8 | MP:0010911 | |
| MousePheno | decreased circulating complement protein level | 1.78e-04 | 4 | 77 | 2 | MP:0020216 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 1.99e-04 | 21 | 77 | 3 | MP:0011453 | |
| MousePheno | absent kidney | 2.03e-04 | 53 | 77 | 4 | MP:0000520 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 2.18e-04 | 296 | 77 | 8 | MP:0010899 | |
| MousePheno | abnormal aorta morphology | 2.36e-04 | 225 | 77 | 7 | MP:0000272 | |
| MousePheno | abnormal head morphology | NPC1 FLNA NEK1 AGAP5 FBLN1 NIBAN1 DSC1 ADAMTS3 HS2ST1 LRP2 LAMA5 KCNQ2 AGAP11 C7 AGAP9 AGAP6 | 3.32e-04 | 1120 | 77 | 16 | MP:0000432 |
| MousePheno | abnormal circulating potassium level | 3.55e-04 | 171 | 77 | 6 | MP:0002668 | |
| MousePheno | abnormal circulating complement protein level | 4.43e-04 | 6 | 77 | 2 | MP:0010215 | |
| MousePheno | abnormal uterus morphology | 4.44e-04 | 415 | 77 | 9 | MP:0001120 | |
| Domain | EGF_1 | VLDLR FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LAMA1 LRP2 LAMA5 UMOD ASTN1 EGFLAM LTBP2 ADAM11 C7 LTBP4 LRP1B SSPOP ADAM28 FBN3 NPNT STAB1 | 7.72e-27 | 255 | 85 | 25 | PS00022 |
| Domain | EGF_2 | VLDLR FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LAMA1 LRP2 LAMA5 UMOD ASTN1 EGFLAM LTBP2 ADAM11 C7 LTBP4 LRP1B SSPOP ADAM28 FBN3 NPNT STAB1 | 2.05e-26 | 265 | 85 | 25 | PS01186 |
| Domain | EGF-like_dom | VLDLR FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LAMA1 LRP2 LAMA5 UMOD ASTN1 EGFLAM LTBP2 ADAM11 C7 LTBP4 LRP1B ADAM28 FBN3 NPNT STAB1 | 1.41e-25 | 249 | 85 | 24 | IPR000742 |
| Domain | EGF-like_CS | VLDLR FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LAMA1 LRP2 LAMA5 UMOD ASTN1 EGFLAM LTBP2 ADAM11 C7 LTBP4 LRP1B ADAM28 FBN3 NPNT STAB1 | 4.43e-25 | 261 | 85 | 24 | IPR013032 |
| Domain | EGF_3 | VLDLR FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LRP2 UMOD ASTN1 EGFLAM LTBP2 ADAM11 C7 LTBP4 LRP1B SSPOP ADAM28 FBN3 NPNT STAB1 | 1.15e-24 | 235 | 85 | 23 | PS50026 |
| Domain | EGF | VLDLR FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LAMA1 LRP2 LAMA5 UMOD ASTN1 EGFLAM LTBP2 ADAM11 LTBP4 LRP1B ADAM28 FBN3 NPNT STAB1 | 1.15e-24 | 235 | 85 | 23 | SM00181 |
| Domain | EGF_CA | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LRP2 UMOD EGFLAM LTBP2 LTBP4 LRP1B FBN3 NPNT STAB1 | 4.99e-21 | 122 | 85 | 17 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LRP2 UMOD EGFLAM LTBP2 LTBP4 LRP1B FBN3 NPNT STAB1 | 6.67e-21 | 124 | 85 | 17 | IPR001881 |
| Domain | Growth_fac_rcpt_ | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 LAMA1 LRP2 LAMA5 UMOD LTBP2 LTBP4 LRP1B FBN3 NPNT STAB1 | 3.78e-19 | 156 | 85 | 17 | IPR009030 |
| Domain | ASX_HYDROXYL | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LRP2 UMOD LTBP2 LTBP4 LRP1B FBN3 NPNT | 3.78e-19 | 100 | 85 | 15 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 CELSR3 LRP2 UMOD LTBP2 LTBP4 LRP1B FBN3 NPNT | 9.48e-19 | 106 | 85 | 15 | IPR000152 |
| Domain | EGF_CA | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 LRP2 UMOD LTBP2 LTBP4 LRP1B FBN3 NPNT | 1.86e-18 | 86 | 85 | 14 | PF07645 |
| Domain | EGF_Ca-bd_CS | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 LRP2 UMOD LTBP2 LTBP4 LRP1B FBN3 NPNT | 1.10e-17 | 97 | 85 | 14 | IPR018097 |
| Domain | EGF_CA | VLDLR FBLN1 NELL2 SCUBE1 FBLN2 FBN1 FBN2 LRP2 UMOD LTBP2 LTBP4 LRP1B FBN3 NPNT | 1.49e-17 | 99 | 85 | 14 | PS01187 |
| Domain | cEGF | 1.92e-13 | 26 | 85 | 8 | IPR026823 | |
| Domain | cEGF | 1.92e-13 | 26 | 85 | 8 | PF12662 | |
| Domain | TB | 3.61e-11 | 7 | 85 | 5 | PF00683 | |
| Domain | - | 9.60e-11 | 8 | 85 | 5 | 3.90.290.10 | |
| Domain | TB | 2.15e-10 | 9 | 85 | 5 | PS51364 | |
| Domain | TB_dom | 2.15e-10 | 9 | 85 | 5 | IPR017878 | |
| Domain | Ldl_recept_a | 1.24e-09 | 45 | 85 | 7 | PF00057 | |
| Domain | - | 1.46e-09 | 46 | 85 | 7 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.99e-09 | 48 | 85 | 7 | PS01209 | |
| Domain | LDLRA_2 | 2.31e-09 | 49 | 85 | 7 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 2.31e-09 | 49 | 85 | 7 | IPR002172 | |
| Domain | LDLa | 2.31e-09 | 49 | 85 | 7 | SM00192 | |
| Domain | EGF | 5.80e-09 | 126 | 85 | 9 | PF00008 | |
| Domain | EGF_extracell | 9.99e-09 | 60 | 85 | 7 | IPR013111 | |
| Domain | EGF_2 | 9.99e-09 | 60 | 85 | 7 | PF07974 | |
| Domain | LDLR_class-A_CS | 2.52e-08 | 40 | 85 | 6 | IPR023415 | |
| Domain | FBN | 9.10e-08 | 3 | 85 | 3 | IPR011398 | |
| Domain | LY | 5.25e-07 | 15 | 85 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.25e-07 | 15 | 85 | 4 | IPR000033 | |
| Domain | Laminin_G_2 | 1.01e-06 | 40 | 85 | 5 | PF02210 | |
| Domain | LamG | 1.64e-06 | 44 | 85 | 5 | SM00282 | |
| Domain | Desmosomal_cadherin | 3.14e-06 | 7 | 85 | 3 | IPR009122 | |
| Domain | Laminin_G | 6.57e-06 | 58 | 85 | 5 | IPR001791 | |
| Domain | ArfGap | 8.70e-06 | 29 | 85 | 4 | SM00105 | |
| Domain | ArfGap | 8.70e-06 | 29 | 85 | 4 | PF01412 | |
| Domain | ARFGAP | 8.70e-06 | 29 | 85 | 4 | PS50115 | |
| Domain | ArfGAP | 8.70e-06 | 29 | 85 | 4 | IPR001164 | |
| Domain | EGF_LAM_2 | 1.00e-05 | 30 | 85 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.00e-05 | 30 | 85 | 4 | PS01248 | |
| Domain | Filamin | 1.46e-05 | 11 | 85 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.46e-05 | 11 | 85 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.46e-05 | 11 | 85 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.46e-05 | 11 | 85 | 3 | IPR017868 | |
| Domain | Laminin_EGF | 1.88e-05 | 35 | 85 | 4 | PF00053 | |
| Domain | EGF_Lam | 1.88e-05 | 35 | 85 | 4 | SM00180 | |
| Domain | EGF_3 | 1.94e-05 | 12 | 85 | 3 | PF12947 | |
| Domain | EGF_dom | 1.94e-05 | 12 | 85 | 3 | IPR024731 | |
| Domain | LAM_G_DOMAIN | 2.62e-05 | 38 | 85 | 4 | PS50025 | |
| Domain | Laminin_EGF | 2.62e-05 | 38 | 85 | 4 | IPR002049 | |
| Domain | Peptidase_M12B_N | 2.91e-05 | 39 | 85 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.91e-05 | 39 | 85 | 4 | PF01562 | |
| Domain | - | 2.91e-05 | 39 | 85 | 4 | 2.120.10.30 | |
| Domain | TIL_dom | 3.19e-05 | 14 | 85 | 3 | IPR002919 | |
| Domain | Ldl_recept_b | 3.19e-05 | 14 | 85 | 3 | PF00058 | |
| Domain | LDLRB | 3.19e-05 | 14 | 85 | 3 | PS51120 | |
| Domain | DISINTEGRIN_1 | 3.22e-05 | 40 | 85 | 4 | PS00427 | |
| Domain | Reprolysin | 3.22e-05 | 40 | 85 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 3.22e-05 | 40 | 85 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.22e-05 | 40 | 85 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 3.22e-05 | 40 | 85 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 3.56e-05 | 41 | 85 | 4 | IPR001762 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.64e-05 | 46 | 85 | 4 | IPR011042 | |
| Domain | - | 7.28e-05 | 95 | 85 | 5 | 2.60.120.200 | |
| Domain | VWC_out | 8.36e-05 | 19 | 85 | 3 | SM00215 | |
| Domain | FacI_MAC | 1.22e-04 | 4 | 85 | 2 | IPR003884 | |
| Domain | FIMAC | 1.22e-04 | 4 | 85 | 2 | SM00057 | |
| Domain | TSP_1 | 1.94e-04 | 63 | 85 | 4 | PF00090 | |
| Domain | Cadherin_cytoplasmic-dom | 1.95e-04 | 25 | 85 | 3 | IPR000233 | |
| Domain | Cadherin_C | 1.95e-04 | 25 | 85 | 3 | PF01049 | |
| Domain | Laminin_aI | 2.03e-04 | 5 | 85 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.03e-04 | 5 | 85 | 2 | PF06008 | |
| Domain | Laminin_II | 2.03e-04 | 5 | 85 | 2 | PF06009 | |
| Domain | Laminin_domII | 2.03e-04 | 5 | 85 | 2 | IPR010307 | |
| Domain | Sterol-sensing | 2.03e-04 | 5 | 85 | 2 | PF12349 | |
| Domain | TSP1 | 2.19e-04 | 65 | 85 | 4 | SM00209 | |
| Domain | TSP1_rpt | 2.19e-04 | 65 | 85 | 4 | IPR000884 | |
| Domain | TSP1 | 2.19e-04 | 65 | 85 | 4 | PS50092 | |
| Domain | Catenin_binding_dom | 3.05e-04 | 29 | 85 | 3 | IPR027397 | |
| Domain | - | 3.05e-04 | 29 | 85 | 3 | 4.10.900.10 | |
| Domain | ANATO | 4.24e-04 | 7 | 85 | 2 | SM00104 | |
| Domain | ANATO | 4.24e-04 | 7 | 85 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 4.24e-04 | 7 | 85 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 4.24e-04 | 7 | 85 | 2 | PS01177 | |
| Domain | Cadherin_pro | 4.24e-04 | 7 | 85 | 2 | PF08758 | |
| Domain | Anaphylatoxin/fibulin | 4.24e-04 | 7 | 85 | 2 | IPR000020 | |
| Domain | ConA-like_dom | 4.91e-04 | 219 | 85 | 6 | IPR013320 | |
| Domain | MetalloPept_cat_dom | 5.09e-04 | 81 | 85 | 4 | IPR024079 | |
| Domain | - | 5.09e-04 | 81 | 85 | 4 | 3.40.390.10 | |
| Domain | Cadherin_pro_dom | 5.63e-04 | 8 | 85 | 2 | IPR014868 | |
| Domain | LAMININ_IVA | 5.63e-04 | 8 | 85 | 2 | PS51115 | |
| Domain | Laminin_B | 5.63e-04 | 8 | 85 | 2 | PF00052 | |
| Domain | Cadherin_pro | 5.63e-04 | 8 | 85 | 2 | SM01055 | |
| Domain | LamB | 5.63e-04 | 8 | 85 | 2 | SM00281 | |
| Domain | Laminin_IV | 5.63e-04 | 8 | 85 | 2 | IPR000034 | |
| Domain | VWFC_1 | 5.83e-04 | 36 | 85 | 3 | PS01208 | |
| Domain | VWC | 6.84e-04 | 38 | 85 | 3 | SM00214 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.51e-10 | 37 | 69 | 7 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.64e-09 | 44 | 69 | 7 | M26969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBLN1 SCUBE1 FBLN2 FBN1 FBN2 ADAMTS3 LAMA1 ADAMTS16 LAMA5 LTBP2 LTBP4 FBN3 | 2.07e-08 | 300 | 69 | 12 | M610 |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.19e-07 | 25 | 69 | 5 | M39713 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.41e-07 | 32 | 69 | 5 | MM14854 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.23e-06 | 39 | 69 | 5 | MM14601 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.18e-05 | 140 | 69 | 6 | M587 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.05e-04 | 96 | 69 | 5 | M39581 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 2.34e-04 | 5 | 69 | 2 | M27759 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN | 2.34e-04 | 5 | 69 | 2 | M47875 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 2.34e-04 | 5 | 69 | 2 | MM15504 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.60e-04 | 258 | 69 | 7 | MM14572 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.01e-04 | 66 | 69 | 4 | M18 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.38e-04 | 68 | 69 | 4 | M27303 | |
| Pathway | WP_FOCAL_ADHESION | 4.20e-04 | 199 | 69 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.20e-04 | 199 | 69 | 6 | M7253 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 4.88e-04 | 7 | 69 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 4.88e-04 | 7 | 69 | 2 | M22049 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 6.49e-04 | 8 | 69 | 2 | M47850 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 6.57e-04 | 35 | 69 | 3 | M16801 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 8.37e-04 | 38 | 69 | 3 | MM14874 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.04e-04 | 39 | 69 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.04e-04 | 39 | 69 | 3 | MM15165 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.15e-03 | 94 | 69 | 4 | M1041 | |
| Pathway | WP_PAFAH1B1_COPY_NUMBER_VARIATION | 1.26e-03 | 11 | 69 | 2 | M48106 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.26e-03 | 11 | 69 | 2 | M158 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.26e-03 | 11 | 69 | 2 | M48099 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.56e-03 | 47 | 69 | 3 | M646 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.99e-03 | 109 | 69 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.12e-03 | 111 | 69 | 4 | M27416 | |
| Pathway | WP_FOCAL_ADHESION | 2.20e-03 | 187 | 69 | 5 | MM15913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.38e-03 | 15 | 69 | 2 | M47663 | |
| Pubmed | NPC1 CFH TRIM33 GPRASP1 VLDLR NELL2 RELN POLR3B FBN1 CELSR3 MYCBP2 LRP2 KCNQ2 ASTN1 TUBGCP5 LRP1B TARBP1 TOP1 USP47 SH3BP5 STAB1 | 3.22e-12 | 1285 | 85 | 21 | 35914814 | |
| Pubmed | 9.81e-11 | 13 | 85 | 5 | 12682087 | ||
| Pubmed | 4.99e-10 | 175 | 85 | 9 | 28071719 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 4.15e-09 | 9 | 85 | 4 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 6.90e-09 | 10 | 85 | 4 | 20664521 | |
| Pubmed | 8.39e-09 | 167 | 85 | 8 | 22159717 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.06e-08 | 248 | 85 | 9 | 24006456 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.08e-08 | 11 | 85 | 4 | 15381706 | |
| Pubmed | Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. | 1.41e-08 | 3 | 85 | 3 | 9006922 | |
| Pubmed | 2.34e-08 | 13 | 85 | 4 | 27713690 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 3.17e-08 | 37 | 85 | 5 | 34323105 | |
| Pubmed | 3.26e-08 | 14 | 85 | 4 | 22453919 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 4.29e-08 | 79 | 85 | 6 | 18757743 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 5.63e-08 | 4 | 85 | 3 | 25034023 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 12429738 | ||
| Pubmed | 5.91e-08 | 16 | 85 | 4 | 30579834 | ||
| Pubmed | TRIM33 AGAP5 CELSR3 SBF1 SZT2 HS2ST1 LAMA5 AGAP11 AGAP9 AGAP6 STAB1 | 7.03e-08 | 529 | 85 | 11 | 14621295 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 9.90e-08 | 18 | 85 | 4 | 39040056 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 8486729 | ||
| Pubmed | NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility. | 1.40e-07 | 5 | 85 | 3 | 32499443 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 7851641 | ||
| Pubmed | 1.50e-07 | 50 | 85 | 5 | 23658023 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.74e-07 | 247 | 85 | 8 | 39238192 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 CFH FBLN1 NELL2 FBN1 SCAP FBN2 CELSR3 MYCBP2 HS2ST1 LAMA1 LAMA5 LTBP2 LRP1B NEK9 | 2.03e-07 | 1201 | 85 | 15 | 35696571 |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 19349279 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 9404003 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFH FLNA FBLN1 NIBAN1 DSC1 DSC2 LRP2 LAMA5 UMOD MUC5B TMC4 LTBP2 C7 CFI | 3.12e-07 | 1070 | 85 | 14 | 23533145 |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 4.77e-07 | 26 | 85 | 4 | 34189436 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 32913108 | ||
| Pubmed | 5.27e-07 | 64 | 85 | 5 | 22261194 | ||
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 7.82e-07 | 8 | 85 | 3 | 32948785 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 32439764 | ||
| Pubmed | 8.67e-07 | 30 | 85 | 4 | 20301299 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.04e-06 | 135 | 85 | 6 | 28675934 | |
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 12122015 | ||
| Pubmed | 1.64e-06 | 146 | 85 | 6 | 27068509 | ||
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 12724416 | ||
| Pubmed | 2.16e-06 | 153 | 85 | 6 | 25037231 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 11790773 | ||
| Pubmed | A forward genetic screen in mice identifies mutants with abnormal cortical patterning. | 2.29e-06 | 11 | 85 | 3 | 23968836 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.31e-06 | 86 | 85 | 5 | 28327460 | |
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 12707304 | ||
| Pubmed | 3.41e-06 | 493 | 85 | 9 | 15368895 | ||
| Pubmed | Assessment of splice variant-specific functions of desmocollin 1 in the skin. | 3.96e-06 | 13 | 85 | 3 | 14673151 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.18e-06 | 97 | 85 | 5 | 27559042 | |
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 15082773 | ||
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 9151674 | ||
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 22665518 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 5.10e-06 | 101 | 85 | 5 | 20551380 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12399449 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21851253 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9886271 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12363388 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 5.90e-06 | 2 | 85 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 5.90e-06 | 2 | 85 | 2 | 21440062 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15131124 | ||
| Pubmed | The laminin response in inflammatory bowel disease: protection or malignancy? | 5.90e-06 | 2 | 85 | 2 | 25347196 | |
| Pubmed | Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo. | 5.90e-06 | 2 | 85 | 2 | 8850569 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 5.90e-06 | 2 | 85 | 2 | 20404337 | |
| Pubmed | Association between vitamin D status and age-related macular degeneration by genetic risk. | 5.90e-06 | 2 | 85 | 2 | 26312598 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 5.90e-06 | 2 | 85 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 5.90e-06 | 2 | 85 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 5.90e-06 | 2 | 85 | 2 | 7744963 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20019771 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 5.90e-06 | 2 | 85 | 2 | 18006876 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26498522 | ||
| Pubmed | Silencing of X-Linked MicroRNAs by Meiotic Sex Chromosome Inactivation. | 5.90e-06 | 2 | 85 | 2 | 26509798 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 5.90e-06 | 2 | 85 | 2 | 24833718 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7689010 | ||
| Pubmed | Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. | 5.90e-06 | 2 | 85 | 2 | 8702639 | |
| Pubmed | A novel mouse desmosomal cadherin family member, desmoglein 1 gamma. | 5.90e-06 | 2 | 85 | 2 | 12631243 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21936007 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24265020 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20529844 | ||
| Pubmed | The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo. | 5.90e-06 | 2 | 85 | 2 | 8737292 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23133647 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10679933 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24867584 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 5.90e-06 | 2 | 85 | 2 | 1852206 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19609566 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8823356 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 5.90e-06 | 2 | 85 | 2 | 24469451 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28252045 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12429739 | ||
| Pubmed | Differential synthesis of type 1 and type 2 desmocollin mRNAs in human stratified epithelia. | 5.90e-06 | 2 | 85 | 2 | 8507556 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28544784 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 5.90e-06 | 2 | 85 | 2 | 12524050 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31302121 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8120105 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 5.90e-06 | 2 | 85 | 2 | 10504303 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15221638 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25803806 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 5.90e-06 | 2 | 85 | 2 | 25524144 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8841408 | ||
| Pubmed | RELN and VLDLR mutations underlie two distinguishable clinico-radiological phenotypes. | 5.90e-06 | 2 | 85 | 2 | 27000652 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 5.90e-06 | 2 | 85 | 2 | 16407178 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10359653 | ||
| Pubmed | Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. | 6.28e-06 | 15 | 85 | 3 | 9847250 | |
| Interaction | IGFL3 interactions | 2.74e-11 | 75 | 85 | 9 | int:IGFL3 | |
| Interaction | ZNF408 interactions | 5.37e-10 | 145 | 85 | 10 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 4.12e-09 | 57 | 85 | 7 | int:ZFP41 | |
| Interaction | NTN5 interactions | 4.73e-08 | 24 | 85 | 5 | int:NTN5 | |
| Interaction | FBXO2 interactions | NPC1 NELL2 FBN1 SCAP FBN2 CELSR3 DSC2 LAMA1 LRP2 LAMA5 LTBP4 LRP1B | 1.52e-07 | 411 | 85 | 12 | int:FBXO2 |
| Interaction | ZNF627 interactions | 1.36e-06 | 20 | 85 | 4 | int:ZNF627 | |
| Interaction | MFAP5 interactions | 2.64e-06 | 52 | 85 | 5 | int:MFAP5 | |
| Interaction | ELN interactions | 6.46e-06 | 29 | 85 | 4 | int:ELN | |
| Interaction | ZNF517 interactions | 6.46e-06 | 29 | 85 | 4 | int:ZNF517 | |
| Interaction | FBLN2 interactions | 8.65e-06 | 66 | 85 | 5 | int:FBLN2 | |
| Interaction | LTBP4 interactions | 9.32e-06 | 67 | 85 | 5 | int:LTBP4 | |
| Interaction | ZNF101 interactions | 1.10e-05 | 33 | 85 | 4 | int:ZNF101 | |
| Interaction | TAFA3 interactions | 1.96e-05 | 78 | 85 | 5 | int:TAFA3 | |
| Interaction | DYRK1A interactions | NPC1 CFH VLDLR FLNC NELL2 FBN1 BRCA1 MYCBP2 LRP2 LRP1B STAB1 | 2.01e-05 | 552 | 85 | 11 | int:DYRK1A |
| Interaction | TIMP2 interactions | 2.22e-05 | 277 | 85 | 8 | int:TIMP2 | |
| Interaction | FBN1 interactions | 6.33e-05 | 51 | 85 | 4 | int:FBN1 | |
| Interaction | NUFIP2 interactions | 6.55e-05 | 417 | 85 | 9 | int:NUFIP2 | |
| Interaction | DEFB125 interactions | 7.84e-05 | 20 | 85 | 3 | int:DEFB125 | |
| Interaction | ZNF224 interactions | 7.84e-05 | 20 | 85 | 3 | int:ZNF224 | |
| Interaction | ZNF77 interactions | 1.05e-04 | 22 | 85 | 3 | int:ZNF77 | |
| Interaction | ATN1 interactions | 1.40e-04 | 187 | 85 | 6 | int:ATN1 | |
| Interaction | HRG interactions | 1.45e-04 | 63 | 85 | 4 | int:HRG | |
| Interaction | FBN2 interactions | 1.64e-04 | 65 | 85 | 4 | int:FBN2 | |
| Cytoband | 18q12.1 | 1.54e-05 | 26 | 85 | 3 | 18q12.1 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.91e-07 | 17 | 56 | 4 | 1291 | |
| GeneFamily | Desmosomal cadherins | 9.76e-07 | 7 | 56 | 3 | 1188 | |
| GeneFamily | ArfGAPs | 3.16e-06 | 33 | 56 | 4 | 395 | |
| GeneFamily | Low density lipoprotein receptors | 7.87e-06 | 13 | 56 | 3 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 5.63e-05 | 4 | 56 | 2 | 628 | |
| GeneFamily | Complement system|Sushi domain containing | 1.87e-04 | 36 | 56 | 3 | 492 | |
| GeneFamily | Fibulins | 2.61e-04 | 8 | 56 | 2 | 556 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.36e-04 | 206 | 56 | 5 | 682 | |
| GeneFamily | Laminin subunits | 6.10e-04 | 12 | 56 | 2 | 626 | |
| GeneFamily | Fibronectin type III domain containing | 1.52e-03 | 160 | 56 | 4 | 555 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.56e-03 | 19 | 56 | 2 | 50 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.15e-03 | 27 | 56 | 2 | 47 | |
| GeneFamily | Ankyrin repeat domain containing | 6.67e-03 | 242 | 56 | 4 | 403 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.35e-02 | 57 | 56 | 2 | 1179 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN1 NELL2 RELN FBLN2 FBN1 FBN2 LAMA1 LAMA5 EGFLAM LTBP2 LTBP4 SSPOP FBN3 NPNT | 2.55e-15 | 196 | 85 | 14 | M3008 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN1 NELL2 RELN FBLN2 FBN1 FBN2 LAMA1 LAMA5 EGFLAM LTBP2 LTBP4 SSPOP NPNT | 5.05e-14 | 191 | 85 | 13 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | FBLN1 NELL2 RELN FBLN2 FBN1 FBN2 LAMA1 LAMA5 EGFLAM LTBP2 LTBP4 SSPOP FBN3 NPNT | 2.75e-13 | 275 | 85 | 14 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | FBLN1 NELL2 RELN FBLN2 FBN1 FBN2 LAMA1 LAMA5 EGFLAM LTBP2 LTBP4 SSPOP NPNT | 4.21e-12 | 270 | 85 | 13 | MM17057 |
| Coexpression | NABA_MATRISOME | FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 ADAMTS3 LAMA1 ADAMTS16 LAMA5 EGFLAM MUC5B LTBP2 ADAM11 LTBP4 SSPOP ADAM28 FBN3 NPNT | 7.46e-11 | 1026 | 85 | 20 | M5889 |
| Coexpression | NABA_MATRISOME | FBLN1 NELL2 RELN SCUBE1 FBLN2 FBN1 FBN2 ADAMTS3 LAMA1 ADAMTS16 LAMA5 EGFLAM MUC5B LTBP2 ADAM11 LTBP4 SSPOP ADAM28 NPNT | 4.24e-10 | 1008 | 85 | 19 | MM17056 |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 1.28e-07 | 37 | 85 | 5 | MM1121 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | CFH RERG FLNC NELL2 SCAP DSC2 ADAMTS3 LAMA5 EGFLAM LTBP2 CFI FBN3 WWC1 SH3BP5 NPNT | 3.94e-07 | 955 | 85 | 15 | M45680 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 5.75e-07 | 300 | 85 | 9 | M39059 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.61e-06 | 174 | 85 | 7 | M45676 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.31e-06 | 194 | 85 | 7 | M39122 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.05e-06 | 200 | 85 | 7 | M5930 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.99e-06 | 35 | 85 | 4 | MM17054 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 5.69e-06 | 137 | 85 | 6 | M40313 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 1.08e-05 | 325 | 85 | 8 | M39053 | |
| Coexpression | JONES_OVARY_T_CELL | 1.19e-05 | 91 | 85 | 5 | M48354 | |
| Coexpression | JONES_OVARY_STROMAL | 1.20e-05 | 156 | 85 | 6 | M48352 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPRASP1 PPARGC1B RELN BRF1 CELSR3 ADAMTS3 MYCBP2 LAMA5 SSH2 LRP1B SSPOP TARBP1 SH3BP5 NPNT | 1.21e-05 | 1106 | 85 | 14 | M39071 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.27e-05 | 44 | 85 | 4 | MM485 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.33e-05 | 240 | 85 | 7 | M39236 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 1.79e-05 | 16 | 85 | 3 | M40964 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 1.84e-05 | 350 | 85 | 8 | M1949 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 2.02e-05 | 256 | 85 | 7 | M10952 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.12e-05 | 357 | 85 | 8 | MM828 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 2.12e-05 | 50 | 85 | 4 | M1259 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.28e-05 | 261 | 85 | 7 | M1834 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 2.48e-05 | 52 | 85 | 4 | MM1118 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 3.42e-05 | 382 | 85 | 8 | M45756 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 3.62e-05 | 385 | 85 | 8 | M39264 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.01e-05 | 117 | 85 | 5 | M39300 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | VIPR1 RERG PPARGC1B NIBAN1 RELN SCUBE1 FBLN2 LAMA1 LRP2 KCNQ2 EGFLAM SPIDR NPNT | 4.08e-05 | 1074 | 85 | 13 | M1941 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 4.08e-05 | 286 | 85 | 7 | M45746 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 4.09e-05 | 59 | 85 | 4 | M47993 | |
| Coexpression | CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL | 4.21e-05 | 195 | 85 | 6 | M39303 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP | 4.59e-05 | 198 | 85 | 6 | M4418 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 4.72e-05 | 199 | 85 | 6 | M9253 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN | 4.85e-05 | 200 | 85 | 6 | M9637 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_UP | 4.85e-05 | 200 | 85 | 6 | M5181 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP | 4.85e-05 | 200 | 85 | 6 | M4299 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP | 4.85e-05 | 200 | 85 | 6 | M4355 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 5.08e-05 | 296 | 85 | 7 | M41675 | |
| Coexpression | SABATES_COLORECTAL_ADENOMA_DN | 5.41e-05 | 299 | 85 | 7 | M14791 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 6.19e-05 | 209 | 85 | 6 | MM1058 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 6.99e-05 | 546 | 85 | 9 | M3837 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 8.60e-05 | 322 | 85 | 7 | M39060 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 9.31e-05 | 567 | 85 | 9 | M2129 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 9.35e-05 | 704 | 85 | 10 | M45672 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.13e-04 | 233 | 85 | 6 | M13273 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 1.71e-04 | 85 | 85 | 4 | M45761 | |
| Coexpression | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN | 2.00e-04 | 35 | 85 | 3 | M13220 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.01e-04 | 493 | 85 | 8 | M19391 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.09e-04 | 166 | 85 | 5 | M39026 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | CFH FAM171A1 FLNA RERG DSC2 LAMA5 TMC4 CFI TOP1 ADAM28 WWC1 NPNT STAB1 | 2.29e-04 | 1276 | 85 | 13 | M39173 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.36e-04 | 505 | 85 | 8 | M39167 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 2.60e-04 | 272 | 85 | 6 | MM3825 | |
| Coexpression | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN | 2.71e-04 | 274 | 85 | 6 | M13014 | |
| Coexpression | GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP | 2.81e-04 | 177 | 85 | 5 | M5641 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.81e-04 | 276 | 85 | 6 | M3063 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN | 2.87e-04 | 8 | 85 | 2 | M9012 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN | 2.87e-04 | 8 | 85 | 2 | MM478 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 2.96e-04 | 179 | 85 | 5 | M8519 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.98e-04 | 40 | 85 | 3 | M5887 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.60e-04 | 289 | 85 | 6 | M2196 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN | 3.90e-04 | 190 | 85 | 5 | M41086 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP | 4.09e-04 | 192 | 85 | 5 | M6592 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 4.12e-04 | 107 | 85 | 4 | M4913 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 4.18e-04 | 193 | 85 | 5 | M39321 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 4.38e-04 | 300 | 85 | 6 | M41708 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 4.46e-04 | 301 | 85 | 6 | M45708 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP | 4.70e-04 | 198 | 85 | 5 | M8407 | |
| Coexpression | GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN | 4.70e-04 | 198 | 85 | 5 | M7228 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | 4.80e-04 | 427 | 85 | 7 | M17923 | |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN | 4.81e-04 | 199 | 85 | 5 | M7998 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN | 4.92e-04 | 200 | 85 | 5 | M9373 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN | 4.92e-04 | 200 | 85 | 5 | M10091 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP | 4.92e-04 | 200 | 85 | 5 | M9633 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 4.92e-04 | 200 | 85 | 5 | M8208 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 4.92e-04 | 200 | 85 | 5 | M3413 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 4.92e-04 | 200 | 85 | 5 | M3675 | |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 4.92e-04 | 200 | 85 | 5 | M6193 | |
| Coexpression | GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP | 4.92e-04 | 200 | 85 | 5 | M8844 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 5.12e-04 | 309 | 85 | 6 | M1973 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 5.41e-04 | 115 | 85 | 4 | M45752 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 5.41e-04 | 115 | 85 | 4 | M19068 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 5.78e-04 | 50 | 85 | 3 | MM403 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL | 6.19e-04 | 584 | 85 | 8 | M45668 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | 6.40e-04 | 587 | 85 | 8 | M17572 | |
| Coexpression | GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR | 6.49e-04 | 52 | 85 | 3 | M39150 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 6.97e-04 | 123 | 85 | 4 | M624 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 7.19e-04 | 124 | 85 | 4 | M45686 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 8.50e-04 | 767 | 85 | 9 | M39209 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | NPC1 CFH FLNA FLNC NIBAN1 SCUBE1 FBN1 FBN2 DSC2 ADAMTS3 SZT2 LAMA1 ADAMTS16 SPIDR LTBP4 | 1.87e-07 | 740 | 84 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | CFH VLDLR FLNA NIBAN1 RELN FBN1 ADAMTS3 LRP2 LAMA5 UMOD CFI NPNT | 2.32e-07 | 456 | 84 | 12 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CFH FLNA RERG FLNC FBLN1 SCUBE1 FBLN2 FBN1 FBN2 ADAMTS3 LAMA1 ADAMTS16 EGFLAM C7 LTBP4 | 3.00e-07 | 768 | 84 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | CFH FLNA RERG FLNC FBLN1 NIBAN1 SCUBE1 FBN1 FBN2 MYLK ADAMTS3 LAMA1 EGFLAM C7 LTBP4 | 3.26e-07 | 773 | 84 | 15 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.05e-07 | 310 | 84 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.43e-07 | 336 | 84 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.04e-06 | 265 | 84 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.42e-06 | 356 | 84 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | FLNA FLNC SCUBE1 FBLN2 FBN1 ADAMTS3 LAMA1 ADAMTS16 EGFLAM LTBP4 | 1.73e-06 | 364 | 84 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | FAM171A1 VLDLR NIBAN1 PER3 DSC2 MYCBP2 LRP2 LAMA5 ROS1 CFI TOP1 WWC1 CLDN9 NPNT | 1.94e-06 | 774 | 84 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | CFH VLDLR FLNA NIBAN1 RELN FBN1 MYLK ADAMTS3 LAMA1 LRP2 LAMA5 UMOD NEURL1B CFI NPNT | 2.34e-06 | 905 | 84 | 15 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | 4.58e-06 | 406 | 84 | 10 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 8.96e-06 | 122 | 84 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 1.04e-05 | 73 | 84 | 5 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | CFH VLDLR FBLN1 FBLN2 FBN1 MYLK ADAMTS3 LRP2 EGFLAM LTBP2 C7 LTBP4 NPNT | 1.10e-05 | 778 | 84 | 13 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | VLDLR FBLN1 NELL2 PDE3B FBN1 FBN2 MYLK BRCA1 LAMA1 ADAMTS16 LRP2 LAMA5 NPNT | 1.18e-05 | 783 | 84 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | NPC1 FLNA FLNC FBLN1 NELL2 SCUBE1 FBN1 FBN2 DSC2 ADAMTS3 LAMA1 ADAMTS16 LTBP4 | 1.42e-05 | 797 | 84 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.53e-05 | 369 | 84 | 9 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#3_top-relative-expression-ranked_500 | 1.69e-05 | 39 | 84 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 2.28e-05 | 388 | 84 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.49e-05 | 146 | 84 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.60e-05 | 496 | 84 | 10 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.64e-05 | 497 | 84 | 10 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500 | 2.95e-05 | 401 | 84 | 9 | gudmap_developingKidney_e11.5_ureteric bud_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 4.95e-05 | 165 | 84 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CFH FLNA FLNC FBLN1 SCUBE1 FBN1 FBN2 MYLK LAMA1 EGFLAM C7 LTBP4 | 5.33e-05 | 777 | 84 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_500 | 5.76e-05 | 53 | 84 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | VLDLR OVOL1 LAMA1 ADAMTS16 LRP2 UMOD KCNQ2 TMC4 CFI WWC1 CLDN9 NPNT | 5.81e-05 | 784 | 84 | 12 | gudmap_developingKidney_e15.5_early proxim tubul_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FLNA FLNC SCUBE1 FBLN2 FBN1 DSC2 ADAMTS3 LAMA1 ADAMTS16 EGFLAM C7 LTBP4 | 6.48e-05 | 793 | 84 | 12 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | CFH VLDLR GGNBP2 FBLN2 MYLK ADAMTS16 EGFLAM LTBP2 LTBP4 JMJD1C TOP1 CLDN9 | 6.97e-05 | 799 | 84 | 12 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | VLDLR NEK1 OVOL1 LAMA1 ADAMTS16 LAMA5 ROS1 TMC4 CFI WWC1 CLDN9 NPNT | 7.13e-05 | 801 | 84 | 12 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.92e-05 | 111 | 84 | 5 | gudmap_developingKidney_e11.5_ureteric bud_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | FAM171A1 RELN OVOL1 MYCBP2 LAMA1 ADAMTS16 LRP2 LAMA5 UMOD WWC1 CLDN9 NPNT | 8.03e-05 | 811 | 84 | 12 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 8.53e-05 | 182 | 84 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.99e-05 | 114 | 84 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | NIBAN1 NELL2 FBLN2 MYLK DSC2 LRP2 LAMA5 ASTN1 TUBGCP5 LTBP4 WWC1 CLDN9 NPNT | 1.11e-04 | 973 | 84 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.14e-04 | 63 | 84 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.15e-04 | 373 | 84 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | RERG NELL2 RELN SCUBE1 ADAMTS3 LAMA1 ADAMTS16 LRP2 KCNQ2 C7 LRP1B FBN3 NPNT | 1.26e-04 | 986 | 84 | 13 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.29e-04 | 123 | 84 | 5 | gudmap_developingKidney_e15.5_S-shaped body_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.31e-04 | 283 | 84 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K3 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | FAM171A1 FLNC FBLN1 PPARGC1B FBLN2 FBN1 ADAMTS16 EGFLAM ROS1 SSH2 LTBP4 SH3BP5 NPNT STAB1 | 1.47e-04 | 1143 | 84 | 14 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 1.50e-04 | 496 | 84 | 9 | PCBC_EB_500 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.62e-04 | 69 | 84 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_500 | 1.67e-04 | 394 | 84 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500 | 1.67e-04 | 394 | 84 | 8 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.72e-04 | 207 | 84 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#1_top-relative-expression-ranked_500 | 2.01e-04 | 73 | 84 | 4 | gudmap_developingKidney_e11.5_ureteric bud_500_k1 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 2.12e-04 | 408 | 84 | 8 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.49e-04 | 418 | 84 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | NIBAN1 OVOL1 DSC2 MYCBP2 LRP2 LAMA5 UMOD TMC4 WWC1 CLDN9 NPNT | 2.64e-04 | 786 | 84 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.70e-04 | 423 | 84 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.73e-04 | 79 | 84 | 4 | gudmap_developingKidney_e11.5_ureteric bud_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.73e-04 | 79 | 84 | 4 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k2 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_top-relative-expression-ranked_1000 | VLDLR PDE3B DSC2 LAMA1 LRP2 ROS1 SSH2 CLDN9 LCMT1 NPNT STAB1 | 3.13e-04 | 802 | 84 | 11 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000 | OVOL1 LAMA1 ADAMTS16 LRP2 LAMA5 ROS1 TMC4 SSH2 WWC1 CLDN9 NPNT | 3.52e-04 | 813 | 84 | 11 | gudmap_developingKidney_e11.5_ureteric bud_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.79e-04 | 337 | 84 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | VLDLR FLNA FLNC SCUBE1 FBN1 FBN2 DSC2 ADAMTS3 SZT2 LAMA1 SPIDR | 4.23e-04 | 831 | 84 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#2_top-relative-expression-ranked_500 | 4.92e-04 | 39 | 84 | 3 | gudmap_developingKidney_e15.5_early proxim tubul_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.09e-04 | 354 | 84 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#2_top-relative-expression-ranked_500 | 5.09e-04 | 93 | 84 | 4 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k2 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.11e-04 | 586 | 84 | 9 | geo_heart_2500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 5.35e-04 | 357 | 84 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.45e-04 | 168 | 84 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | FLNC NELL2 SCUBE1 FBN1 FBN2 SBF1 LAMA1 LRP2 ASTN1 LTBP2 ADAM11 LTBP4 NEK9 FBN3 SH3BP5 | 5.78e-04 | 1466 | 84 | 15 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.90e-04 | 171 | 84 | 5 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k3 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 5.97e-04 | 97 | 84 | 4 | GSM777043_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_200 | 6.39e-04 | 174 | 84 | 5 | gudmap_kidney_adult_RenalCapsule_200 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 6.86e-04 | 487 | 84 | 8 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_500 | 7.62e-04 | 495 | 84 | 8 | PCBC_ECTO_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 7.82e-04 | 497 | 84 | 8 | PCBC_ECTO_fibroblast_500 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 8.73e-04 | 281 | 84 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 8.73e-04 | 281 | 84 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | 8.99e-04 | 390 | 84 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#5 | 9.13e-04 | 391 | 84 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K5 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 9.26e-04 | 189 | 84 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_500 | 9.40e-04 | 393 | 84 | 7 | gudmap_developingKidney_e15.5_early proxim tubul_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 1.03e-03 | 783 | 84 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.08e-03 | 293 | 84 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.10e-03 | 790 | 84 | 10 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.13e-03 | 406 | 84 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 1.16e-03 | 795 | 84 | 10 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_200 | 1.17e-03 | 13 | 84 | 2 | gudmap_developingKidney_e11.5_ureteric bud_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_500 | 1.21e-03 | 53 | 84 | 3 | gudmap_developingKidney_e11.5_ureteric bud_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 1.24e-03 | 412 | 84 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_500 | 1.24e-03 | 412 | 84 | 7 | gudmap_kidney_e15.5_Podocyte_MafB_500 | |
| CoexpressionAtlas | MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.34e-03 | 418 | 84 | 7 | PCBC_ratio_MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_500 | 1.40e-03 | 122 | 84 | 4 | gudmap_developingGonad_P2_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_500 | 1.40e-03 | 122 | 84 | 4 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.45e-03 | 123 | 84 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.55e-03 | 827 | 84 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | CFH NIBAN1 RELN FBLN2 FBN1 SCN1B LAMA1 LTBP2 AGAP11 FCRLA C7 | 1.56e-03 | 975 | 84 | 11 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | NIBAN1 NELL2 SCUBE1 FBLN2 ADAMTS3 LRP2 LAMA5 ASTN1 LTBP4 WWC1 NPNT | 1.58e-03 | 976 | 84 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#5 | 1.65e-03 | 59 | 84 | 3 | Facebase_RNAseq_e8.5_Floor Plate_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | NIBAN1 NELL2 FBLN2 DSC2 LRP2 LAMA5 ASTN1 LTBP4 WWC1 CLDN9 NPNT | 1.68e-03 | 984 | 84 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | RELN SCUBE1 FBN1 LAMA1 LRP2 EGFLAM LTBP2 CFI SSPOP ADAM28 NPNT | 1.71e-03 | 986 | 84 | 11 | PCBC_ratio_ECTO_vs_SC_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.77e-03 | 130 | 84 | 4 | gudmap_developingKidney_e15.5_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.77e-03 | 130 | 84 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.77e-03 | 439 | 84 | 7 | GSM777059_500 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#1_top-relative-expression-ranked_100 | 1.79e-03 | 16 | 84 | 2 | gudmap_kidney_adult_RenalCortexMixed_Std_k1_100 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-12 | 184 | 85 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-12 | 184 | 85 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-12 | 184 | 85 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 5.09e-12 | 198 | 85 | 10 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-10 | 192 | 85 | 9 | 11867f30f0b420c18cb0b34d3990237aa737a0e8 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.33e-10 | 194 | 85 | 9 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.33e-10 | 194 | 85 | 9 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.33e-10 | 194 | 85 | 9 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-10 | 196 | 85 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-10 | 197 | 85 | 9 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-10 | 198 | 85 | 9 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-10 | 198 | 85 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 1.59e-10 | 198 | 85 | 9 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.59e-10 | 198 | 85 | 9 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-10 | 199 | 85 | 9 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.74e-10 | 200 | 85 | 9 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-10 | 200 | 85 | 9 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.74e-10 | 200 | 85 | 9 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-10 | 200 | 85 | 9 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-10 | 200 | 85 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-10 | 200 | 85 | 9 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.74e-10 | 200 | 85 | 9 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.74e-10 | 200 | 85 | 9 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | 367C-Fibroblasts|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-10 | 200 | 85 | 9 | c5aaa20c59b9f11b8abdf5de9e3fc54f4e6e39f7 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-09 | 178 | 85 | 8 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-09 | 181 | 85 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.58e-09 | 185 | 85 | 8 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-09 | 188 | 85 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-09 | 189 | 85 | 8 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.05e-09 | 189 | 85 | 8 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.18e-09 | 190 | 85 | 8 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.31e-09 | 191 | 85 | 8 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-09 | 191 | 85 | 8 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.31e-09 | 191 | 85 | 8 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.31e-09 | 191 | 85 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.45e-09 | 192 | 85 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-09 | 192 | 85 | 8 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-09 | 192 | 85 | 8 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.60e-09 | 193 | 85 | 8 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.75e-09 | 194 | 85 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.75e-09 | 194 | 85 | 8 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 3.90e-09 | 195 | 85 | 8 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 3.90e-09 | 195 | 85 | 8 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-09 | 195 | 85 | 8 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.90e-09 | 195 | 85 | 8 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.90e-09 | 195 | 85 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.90e-09 | 195 | 85 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-09 | 195 | 85 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.90e-09 | 195 | 85 | 8 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-09 | 196 | 85 | 8 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.06e-09 | 196 | 85 | 8 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-09 | 196 | 85 | 8 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 4.06e-09 | 196 | 85 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.06e-09 | 196 | 85 | 8 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-09 | 197 | 85 | 8 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.23e-09 | 197 | 85 | 8 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.23e-09 | 197 | 85 | 8 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-09 | 197 | 85 | 8 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 4.23e-09 | 197 | 85 | 8 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-09 | 197 | 85 | 8 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 4.23e-09 | 197 | 85 | 8 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-09 | 198 | 85 | 8 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-09 | 198 | 85 | 8 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-09 | 198 | 85 | 8 | 4961a3e9b953679648586afed04869ff36b81820 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-09 | 198 | 85 | 8 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.40e-09 | 198 | 85 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-09 | 198 | 85 | 8 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.57e-09 | 199 | 85 | 8 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.57e-09 | 199 | 85 | 8 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.57e-09 | 199 | 85 | 8 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.57e-09 | 199 | 85 | 8 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-09 | 199 | 85 | 8 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-09 | 199 | 85 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.76e-09 | 200 | 85 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.76e-09 | 200 | 85 | 8 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | distal-1-mesenchymal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.76e-09 | 200 | 85 | 8 | 7623f82bd85a0ff7e2097e9281551208dfc602a8 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.76e-09 | 200 | 85 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-09 | 200 | 85 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.76e-09 | 200 | 85 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | distal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.76e-09 | 200 | 85 | 8 | 7a79a2de78325d4f1c4535969106a0a44249028c | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.76e-09 | 200 | 85 | 8 | 87a5a0c252c08ba10316c21f6a9d5244c4d98c74 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 4.76e-09 | 200 | 85 | 8 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.76e-09 | 200 | 85 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | medial-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.76e-09 | 200 | 85 | 8 | 6ccf44f10d2cee5f48b8f05bd9a1b94057184d56 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-09 | 200 | 85 | 8 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.76e-09 | 200 | 85 | 8 | 5ee1318a74ca28a81bd81c20c611de84c17636b0 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.76e-09 | 200 | 85 | 8 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-09 | 200 | 85 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.76e-09 | 200 | 85 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.76e-09 | 200 | 85 | 8 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-08 | 160 | 85 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-08 | 160 | 85 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.92e-08 | 164 | 85 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.59e-08 | 169 | 85 | 7 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.22e-08 | 173 | 85 | 7 | 11e95a60b5f6f07f27154a23203bac431e7528c6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-08 | 175 | 85 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.75e-08 | 176 | 85 | 7 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.33e-08 | 179 | 85 | 7 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 5.75e-08 | 181 | 85 | 7 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-08 | 186 | 85 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| Computational | Metal / Ca ion binding. | 1.06e-05 | 133 | 62 | 7 | MODULE_324 | |
| Computational | DRG (dorsal root ganglia) genes. | 6.15e-05 | 384 | 62 | 10 | MODULE_2 | |
| Computational | Genes in the cancer module 58. | 2.26e-04 | 21 | 62 | 3 | MODULE_58 | |
| Computational | Complement. | 2.98e-04 | 23 | 62 | 3 | MODULE_130 | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 7.14e-07 | 196 | 85 | 8 | 2198_DN | |
| Drug | funiferine N-oxide | 1.08e-06 | 49 | 85 | 5 | CID000191631 | |
| Drug | Piperidino acetanilide | 1.74e-06 | 7 | 85 | 3 | CID000078402 | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 9.73e-06 | 199 | 85 | 7 | 5992_UP | |
| Drug | AC1L1BJ8 | 2.85e-05 | 47 | 85 | 4 | CID000001462 | |
| Drug | nNOS inhibitor I | 3.95e-05 | 51 | 85 | 4 | CID000656911 | |
| Drug | 2-amino-2-methyl-1-propanol | 4.57e-05 | 346 | 85 | 8 | ctd:C006551 | |
| Drug | TEMPO | 8.03e-05 | 61 | 85 | 4 | CID002724126 | |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 8.61e-05 | 193 | 85 | 6 | 3251_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 8.61e-05 | 193 | 85 | 6 | 4322_UP | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 6433_UP | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 5428_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 3835_DN | |
| Drug | 0393-0188; Down 200; 10uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 7531_DN | |
| Drug | nigrosine | 9.60e-05 | 24 | 85 | 3 | CID005359556 | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 4134_UP | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 3686_UP | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2304_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2307_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; HL60; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 2436_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 4414_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 2848_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 6983_UP | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 4704_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 4142_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 3344_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 3274_UP | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 7247_DN | |
| Drug | valdecoxib; Down 200; 10uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 6403_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 4818_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 4824_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 6502_UP | |
| Drug | dG X | 1.37e-04 | 5 | 85 | 2 | CID000093001 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:1969 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.23e-08 | 3 | 84 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | vascular endothelial growth factor A measurement | 4.81e-06 | 12 | 84 | 3 | EFO_0010804 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 7.92e-06 | 14 | 84 | 3 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.61e-05 | 53 | 84 | 4 | C4707243 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.40e-05 | 3 | 84 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | Drusen, Radial, Autosomal Dominant | 2.40e-05 | 3 | 84 | 2 | C1852021 | |
| Disease | Malattia Leventinese | 2.40e-05 | 3 | 84 | 2 | C1852020 | |
| Disease | Weill-Marchesani syndrome | 2.40e-05 | 3 | 84 | 2 | C0265313 | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.40e-05 | 3 | 84 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | DOYNE HONEYCOMB RETINAL DYSTROPHY | 2.40e-05 | 3 | 84 | 2 | C1832174 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 2.40e-05 | 3 | 84 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 2.40e-05 | 3 | 84 | 2 | C1869114 | |
| Disease | scoliosis (is_implicated_in) | 4.79e-05 | 4 | 84 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 4.79e-05 | 4 | 84 | 2 | cv:C0265313 | |
| Disease | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 measurement | 4.79e-05 | 4 | 84 | 2 | EFO_0801407 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 4.79e-05 | 4 | 84 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | HELLP Syndrome | 4.79e-05 | 4 | 84 | 2 | C0162739 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology) | 7.96e-05 | 5 | 84 | 2 | DOID:0050431 (implicated_via_orthology) | |
| Disease | desmocollin-2 measurement | 7.96e-05 | 5 | 84 | 2 | EFO_0021936 | |
| Disease | insulin-like growth factor I measurement | 7.96e-05 | 5 | 84 | 2 | EFO_0801702 | |
| Disease | Complement deficiency disease | 1.14e-04 | 33 | 84 | 3 | C0272242 | |
| Disease | ERO1-like protein alpha measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0801582 | |
| Disease | serine/threonine-protein kinase PAK 3 measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0020728 | |
| Disease | receptor-type tyrosine-protein kinase flt3 measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0020703 | |
| Disease | protocadherin beta-4 measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0801976 | |
| Disease | cytosolic non-specific dipeptidase measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0020310 | |
| Disease | cyclin-dependent kinase 8:cyclin-c complex measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0020297 | |
| Disease | zinc finger protein 276 measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0802227 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0801372 | |
| Disease | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0020637 | |
| Disease | regulator of G-protein signaling 8 measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0801997 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 3 measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0020343 | |
| Disease | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0801881 | |
| Disease | BCL-2-like protein 1 measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0020177 | |
| Disease | uroplakin-3b-like protein measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0802204 | |
| Disease | kinesin-like protein KIF16B measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0801747 | |
| Disease | macrophage-stimulating protein receptor measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0020550 | |
| Disease | tumor necrosis factor receptor superfamily member 3 measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0020813 | |
| Disease | stabilin-2 measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0020752 | |
| Disease | desmoglein-1 measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0020321 | |
| Disease | cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0801513 | |
| Disease | zinc-alpha-2-glycoprotein measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0802228 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0801373 | |
| Disease | opioid-binding protein/cell adhesion molecule measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0020618 | |
| Disease | chromobox protein homolog 5 measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0020258 | |
| Disease | kallikrein-6 measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0801739 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 2.22e-04 | 8 | 84 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | age at initiation of corrective lens use | 2.22e-04 | 8 | 84 | 2 | EFO_0021781 | |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0803293 | |
| Disease | epididymal-specific lipocalin-10 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0801576 | |
| Disease | mitral valve prolapse (is_implicated_in) | 2.85e-04 | 9 | 84 | 2 | DOID:988 (is_implicated_in) | |
| Disease | dickkopf-like protein 1 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020324 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0801514 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 1 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020342 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020296 | |
| Disease | C3 glomerulopathy | 2.85e-04 | 9 | 84 | 2 | C4087273 | |
| Disease | Atypical hemolytic-uremic syndrome | 2.85e-04 | 9 | 84 | 2 | cv:C2931788 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0801463 | |
| Disease | oxysterols receptor LXR-beta measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0801865 | |
| Disease | apolipoprotein D measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020156 | |
| Disease | Hemolytic-uremic syndrome | 2.85e-04 | 9 | 84 | 2 | cv:C0019061 | |
| Disease | complement component C8 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0008094 | |
| Disease | mast cell-expressed membrane protein 1 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0801787 | |
| Disease | interleukin-34 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020505 | |
| Disease | kallikrein-14 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020513 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0021876 | |
| Disease | RNA-binding protein 24 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0802030 | |
| Disease | Glaucoma | 2.85e-04 | 9 | 84 | 2 | C0017601 | |
| Disease | vascular endothelial growth factor A, isoform 121 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020847 | |
| Disease | heterogeneous nuclear ribonucleoprotein q measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0020443 | |
| Disease | cortical thickness | NELL2 RELN SCUBE1 FBN1 FBN2 ADAMTS3 MYCBP2 LAMA1 SSH2 JMJD1C STAB1 | 3.13e-04 | 1113 | 84 | 11 | EFO_0004840 |
| Disease | creatinine measurement, glomerular filtration rate | 3.55e-04 | 117 | 84 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | Secreted frizzled-related protein 3 measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0008277 | |
| Disease | serine/threonine-protein kinase 16 measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0020724 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0801535 | |
| Disease | DNA repair protein rad51 homolog 1 measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0020330 | |
| Disease | tropomyosin beta chain measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0020787 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 3.55e-04 | 10 | 84 | 2 | C2931788 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.55e-04 | 10 | 84 | 2 | cv:C4707243 | |
| Disease | interleukin-37 measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0020506 | |
| Disease | insulin growth factor-like family member 3 measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0801700 | |
| Disease | response to fenofibrate | 3.96e-04 | 50 | 84 | 3 | GO_1901557 | |
| Disease | tumor necrosis factor receptor superfamily member 11B measurement | 4.33e-04 | 11 | 84 | 2 | EFO_0020801 | |
| Disease | gastrin-releasing peptide measurement | 4.33e-04 | 11 | 84 | 2 | EFO_0022000 | |
| Disease | interleukin-10 receptor subunit alpha measurement | 4.33e-04 | 11 | 84 | 2 | EFO_0021890 | |
| Disease | Marfan Syndrome | 4.33e-04 | 11 | 84 | 2 | C0024796 | |
| Disease | guanylate-binding protein 6 measurement | 4.33e-04 | 11 | 84 | 2 | EFO_0801662 | |
| Disease | glycerol-3-phosphate dehydrogenase 1-like protein measurement | 4.33e-04 | 11 | 84 | 2 | EFO_0801640 | |
| Disease | oncostatin-M measurement | 5.19e-04 | 12 | 84 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 5.19e-04 | 12 | 84 | 2 | EFO_0020833 | |
| Disease | autistic disorder (is_marker_for) | 5.19e-04 | 12 | 84 | 2 | DOID:12849 (is_marker_for) | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 6.12e-04 | 13 | 84 | 2 | EFO_0010592 | |
| Disease | kallikrein-12 measurement | 6.12e-04 | 13 | 84 | 2 | EFO_0008194 | |
| Disease | tyrosine-protein phosphatase non-receptor type 1 measurement | 6.12e-04 | 13 | 84 | 2 | EFO_0020834 | |
| Disease | ascending aortic diameter | 6.98e-04 | 140 | 84 | 4 | EFO_0021787 | |
| Disease | FEV/FEC ratio | TRIM33 RERG FBLN1 PPARGC1B NELL2 FBN1 LTBP2 SSH2 LTBP4 JMJD1C NPNT | 7.12e-04 | 1228 | 84 | 11 | EFO_0004713 |
| Disease | wet macular degeneration | 7.13e-04 | 14 | 84 | 2 | EFO_0004683 | |
| Disease | complement factor H measurement, protein binding measurement | 7.13e-04 | 14 | 84 | 2 | EFO_0008097, EFO_0010742 | |
| Disease | aortic measurement | 7.65e-04 | 251 | 84 | 5 | EFO_0020865 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVDCITGEDEVGCAG | 281 | P05156 | |
| LSGADVGECSSGICD | 556 | Q63HQ2 | |
| VGECSSGICDEASCI | 561 | Q63HQ2 | |
| REEVNETCGEGDGCT | 476 | Q8TF27 | |
| SREEVNETCGEGDGC | 656 | Q5VTM2 | |
| EMGEDCDCGTSEECT | 416 | Q9UKQ2 | |
| CSGASSPECEVERGD | 371 | O60239 | |
| FVEAGEECDCGSVQE | 451 | O75078 | |
| AVNECDIAETCTGDS | 506 | O75078 | |
| CEGGFRISEENETTC | 901 | P08603 | |
| GEEGCCDAVGTASLT | 366 | Q6P1W5 | |
| TGCSDVDECEVGGHN | 1276 | Q75N90 | |
| NGDCVDFDECTTLVG | 1881 | Q75N90 | |
| AGSVGCCSERQEEDG | 866 | Q02487 | |
| TETCPEGSDCGESRE | 711 | O14525 | |
| GCDNVLGSDAVEDVC | 721 | Q8TE57 | |
| HGSCEEVNETCGEGD | 586 | Q5VW22 | |
| LVSDGSGGCIAEEDC | 841 | Q9HC84 | |
| QSGSECGTTVCTPED | 796 | Q5VUB5 | |
| EDGNCSLIISDVCGD | 1861 | Q15746 | |
| DDCGDGSDEVGCVHS | 991 | Q9NZR2 | |
| NSESCTIGDDGSVEC | 4331 | Q9NZR2 | |
| SDNSDGEIASECECD | 1166 | Q96PY6 | |
| VSCGDDFTVCVTDEG | 431 | Q8TD19 | |
| SCETDIDECSDGFVQ | 551 | Q99435 | |
| SGESCEDIDECGTGR | 596 | Q99435 | |
| APDGRTCVDVDECAT | 161 | Q6UXI9 | |
| KACGSTEDGNTCVEV | 416 | Q9H3C7 | |
| EGSDVACTEGICNHD | 481 | Q9H3C7 | |
| ACVSAAVSDESVAGD | 616 | Q8IX03 | |
| TGESFLQDDSCCEIG | 1711 | Q15652 | |
| AKEGETCGAEDNDSC | 496 | P98095 | |
| GVDLEGACEASLACS | 101 | Q6P4F2 | |
| CVTCENEDSADGAAT | 1176 | P56645 | |
| EGESDTDSDLCTPCG | 836 | O43526 | |
| DCCSGKSGEEENIFS | 596 | Q13370 | |
| GEAATFTVDCSEAGE | 1171 | Q14315 | |
| GGDVCVDRSSESVTC | 666 | Q96RT8 | |
| CDGVRTCTHGEDEDE | 96 | Q5T700 | |
| DGSDEVGCVLNCTAS | 1176 | P98164 | |
| CESDFTDGTCEDLTG | 431 | O15230 | |
| LEACGPGSSCSSEEE | 856 | Q969R2 | |
| GSVGCCSFIGEDLDD | 731 | Q02413 | |
| EECGCTSESQEGHVL | 216 | O14753 | |
| GGSTCTECGILAEDT | 2911 | P78509 | |
| TESGFEDAETCDVAG | 811 | O95248 | |
| GCDESVDEVTAPCSC | 226 | O15118 | |
| GVSCEDVNECITGSH | 211 | P23142 | |
| GEAASGCESETSVSE | 1366 | P38398 | |
| GCESETSVSEDCSGL | 1371 | P38398 | |
| SECSVTCGEGTEVRQ | 976 | O15072 | |
| EGPVCTEESSCHTED | 36 | Q7L513 | |
| CTVCTPDGSEVDVDV | 1686 | P21333 | |
| TGDGFTCTDLDECSE | 1396 | P35555 | |
| TGSSCEDVDECEGNH | 2561 | P35555 | |
| ECEEEGFSICVEVNG | 796 | P10643 | |
| EGGTSCQDVDECATT | 1211 | Q14767 | |
| VNGSCEDVDECATGG | 351 | Q8N2S1 | |
| EEDLCQSGICTNTDG | 926 | Q8N2S1 | |
| SVGCCSDRQEEEGLE | 861 | Q08554 | |
| GTTGCTDVDECEIGA | 1361 | P35556 | |
| TGDGFTCSDVDECAE | 1441 | P35556 | |
| DATGLNCEDVDECDG | 2606 | P35556 | |
| TGEDCELDTEAGRCV | 1466 | Q9NYQ7 | |
| SVDVDECSEGTDDCH | 31 | Q8IWY4 | |
| EGVLCCSSEEVSSGI | 996 | Q12770 | |
| DAASVESGVGVSCES | 526 | Q5JY77 | |
| GEEGDTSACCVVTES | 1491 | Q5T011 | |
| EDNASAVGFCVECGE | 221 | Q9UPN9 | |
| SCEAVGQGEEESCRE | 486 | A2VEC9 | |
| GQGEEESCREECVSG | 491 | A2VEC9 | |
| QDGSDEDGCVDCVLA | 2491 | A2VEC9 | |
| TSSCDADDEGVRGTC | 16 | Q9UIC8 | |
| DPSEAGHCDSVTGEC | 856 | P25391 | |
| AGSVSDGCTDEGQCH | 956 | P25391 | |
| KTFDECVAEGGSDCA | 196 | Q7LGA3 | |
| EEEDSGVSPTCSDHC | 821 | Q86YN6 | |
| ELSAVGSVCSDADCQ | 4366 | O75592 | |
| ECSACTGEGNITEIF | 146 | Q96A58 | |
| SREEVNETCGEGDGC | 611 | A6NIR3 | |
| GAQCTTCVEDEGAKA | 101 | O95484 | |
| DSGESDQCSEGSVGC | 201 | P32241 | |
| FTGDGLTCVDLDECA | 56 | P07911 | |
| SSVEGTCEECSIDED | 291 | P07911 | |
| KCTEEGDASQQEGCT | 831 | Q9BZQ8 | |
| SSPCASEADSGEEEC | 16 | Q76I76 | |
| EEDGTKVNCTCGATA | 186 | Q9Y5K1 | |
| DEGAVEISDCASCAS | 146 | Q14159 | |
| QITCGGDSEAEDCKT | 451 | Q7Z404 | |
| SACGGCVEVDSETEA | 16 | Q07699 | |
| GECTVCFDGEVDTVI | 501 | A8MQ27 | |
| CSATGNDSCGVEADT | 176 | Q8NE00 | |
| TESCTDSGAENEGSC | 431 | Q96K76 | |
| ADGKTSCVCRESEVG | 336 | Q9NY15 | |
| CRESCEVGCSSAEGA | 76 | P08922 | |
| SSDAFEVDVCGQCGL | 1071 | Q9NW08 | |
| GDAVCTACGSVLEDN | 21 | Q92994 | |
| AVEVSAELGADCTCG | 291 | Q13395 | |
| GETADTVGCCSLRVE | 496 | P11387 | |
| DSGEDEENCGNITCS | 141 | P98155 |